27 results
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
WILL CAUSE IRREPARABLE INJURY AND MONEY DAMAGES WILL NOT PROVIDE AN ADEQUATE REMEDY THEREFOR, AND IN THE EVENT OF SUCH A BREACH ALL PARTIES CONSENT
8-K
EX-10.3
w33p15fw10oizk8i
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
ph2zkdt9i5k
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
10-K
pypbo6 j31o8622xnyp
25 Mar 21
Annual report
12:00am
424B4
oh86rtg6jg
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
antwa1q8s xkyx1fio8
6 Jan 21
Draft registration statement
12:00am
10-Q
v4b97ceob6 b1go
12 Nov 20
Quarterly report
4:16pm